Innospec Inc. has grown revenue −3.6% a year over three years and 9.1% a year over five, with earnings per share compounding at −4.0%. Revenue growth, 3-year annual rate: −3.6% (Specialty Chemicals median +3.3%). Revenue growth, 5-year rate: +9.1%, growth has slowed since the five-year average. Earnings per share, 3-year rate: −4.0%, earnings lagged revenue: the growth is costing something. Years of annual history on file: 17, FY2009 to FY2025, as filed.

IOSPInnospec Inc.

Basic MaterialsUSD

$95.62

$65.1252 weeks$95.62

Is it growing?

Is IOSP growing?

Innospec Inc. has grown revenue −3.6% a year over three years and 9.1% a year over five, with earnings per share compounding at −4.0%.

−3.6%

Revenue growth, 3-year annual rate · Specialty Chemicals median +3.3% · shrinking · compounded from trailing twelve-month revenue

Revenue growth, 5-year rate: +9.1%
Revenue growth, 5-year rate · −3.6% over three · growth has slowed since the five-year average
Earnings per share, 3-year rate: −4.0%
Earnings per share, 3-year rate · revenue −3.6% · earnings lagged revenue: the growth is costing something
Years of annual history on file: 17
Years of annual history on file · FY2009 to FY2025, as filed